$45.75
0.250.55%
At Close: -
$38.00
-7.75-16.94%
After Hours: Apr 26, 8:29 AM EDT
15 minutes delayed
Belite Bio
BLTENASDAQ
Belite Bio (NASDAQ:BLTE) Stock Quotes, Forecast and News Summary
Belite Bio Stock (NASDAQ: BLTE) stock price, news, charts, stock research, profile.
| Open | $45.60 |
| Close | $45.75 |
| Volume / Avg. | 24.45K / 50.82K |
| Day Range | 45.14 - 46.24 |
| 52 Wk Range | 12.53 - 50.15 |
| Market Cap | $1.13B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 0.3% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Belite Bio Inc
Sector
Health Care
Industry
Pharmaceuticals
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel thera...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Belite Bio (BLTE) stock?
You can purchase shares of Belite Bio (NASDAQ:BLTE) through any online brokerage.
Who are Belite Bio (BLTE) competitors?
Other companies in Belite Bio’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Neumora Therapeutics (NASDAQ:NMRA).
What is the target price for Belite Bio (BLTE) stock?
There is no analysis for Belite Bio.
What is the forecast for Belite Bio (BLTE) stock?
Belite Bio has a consensus price target of $40.20.
Current stock price for Belite Bio (BLTE)?
The stock price for Belite Bio (NASDAQ: BLTE) is $45.75 last updated July 3, 2024 at 1:00 PM EDT.
Does Belite Bio (BLTE) pay a dividend?
There are no upcoming dividends for Belite Bio.
When is Belite Bio (NASDAQ:BLTE) reporting earnings?
Belite Bio’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Belite Bio (BLTE) going to split?
There is no upcoming split for Belite Bio.
What sector and industry does Belite Bio (BLTE) operate in?
Belite Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.